07:00 , Mar 29, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Lymphoma Epstein-Barr nuclear antigen 3B (EBNA3B) Mouse and patient sample studies suggest increasing EBNA3B signaling could help prevent Epstein-Barr virus (EBV)-associated...